PRLR and metabolic dysfunction-associated steatotic liver disease: When circulating PRL levels were reduced in patients with NAFLD, the human hepatic PRLR expression was downregulated concomitantly, and PRL intervention could enhance the expression of PRLR in HepG2 cells.